College News

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.

The University of Oklahoma Health Sciences has achieved a new Carnegie Classification for its research enterprise and medical school program from the American Council on Education and the Carnegie Foundation for the Advancement of Teaching.

Two University of Oklahoma researchers, Rodney Tweten, Ph.D., and Jizhong “Joe” Zhou, Ph.D., have been elected to the prestigious National Academy of Sciences, one of the highest honors a scientist can receive. OU is the only university in Oklahoma with representation in the organization, and this marks the first time two OU faculty members have been elected in the same year.

In a study published Wednesday in the Proceedings of the National Academy of Sciences (PNAS), University of Oklahoma researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their findings center on ZIP4, a protein that transports zinc throughout the body and sets off a cascade of events that drive tumor growth.

Oklahoma Children’s Hospital OU Health is proud to announce its partnership as an affiliate hub site in the Pediatric Pandemic Network (PPN), significantly expanding the network’s reach to Region 6, which encompasses Oklahoma and surrounding states. This participation is made possible through a partnership with the University of Oklahoma. The addition will help ensure children across the region have access to critical care during health crises, such as pandemics, by enhancing pediatric preparedness and readiness in both urban and rural areas.